Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gel-E
AddedFeb 17, 2024
UpdatedJun 18, 2026
Gel-E

Gel-E

Closed

Gel-E, Inc.: Providing non-dilutive grant funded healthcare products for wound care in the US.

HQ
College Park, MD, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Gel-E, Inc. was founded with the mission to revolutionize wound care through innovative healthcare products. The company focuses on developing gels, foams, sponges, bandages, and transparent films designed to effectively treat wound bleeding. Gel-E aims to serve a broad market that includes surgeons, nurses, caretakers, and parents across the United States. Their vision is to provide accessible and effective wound care solutions that improve patient outcomes and simplify the treatment process.

Notable individuals affiliated with Gel-E include experts in medical technology and healthcare innovation. The company has secured non-dilutive grant funding to support its research and product development efforts. Key achievements include the successful introduction of their advanced wound care products into the market, which have been well-received by healthcare professionals. Gel-E's impact is significant in enhancing the quality of wound care and providing reliable solutions for bleeding control, thereby contributing positively to the healthcare industry.

Gel-E - Similar Companies

GelSana Therapeutics logo

GelSana Therapeutics

KleenGel logo

KleenGel

Gel4Med logo

Gel4Med

gelformed.com

Emergency Medical Innovation logo

Emergency Medical Innovation

Innovative Trauma Care logo

Innovative Trauma Care

Gel Hydration Technologies logo

Gel Hydration Technologies

gelhydration.com

Newco Wound Care logo

Newco Wound Care

RenovoDerm logo

RenovoDerm

WoundForce logo

WoundForce

Biofisica logo

Biofisica

biofisica.com

Eluciderm logo

Eluciderm

eluciderm.com

Aleo BME logo

Aleo BME

Tympanogen logo

Tympanogen

tympanogen.com

Healogics logo

Healogics

healogics.com

Cresilon logo

Cresilon

cresilon.com

Gel-E - Quick Facts

Who are Gel-E's competitors?

Companies similar to Gel-E include GelSana Therapeutics, KleenGel, Gel4Med and Emergency Medical Innovation.

When was Gel-E founded?

Gel-E was founded in 2007.

Where is Gel-E's headquarters located?

Gel-E's headquarters is located in College Park, MD, US.

When was Gel-E's last funding round?

Gel-E's most recent funding round was for $3.1M (USD) in July 2017.

How much has Gel-E raised to-date?

As of Jul 13, 2017, Gel-E has raised a total of $4.1M (USD).

Gel-E - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Wound Care
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities